Intuitive Surgical Aktie
| 537,88USD | -4,73USD | -0,87% |
WKN: 888024 / ISIN: US46120E6023
Aktionärsstruktur
| Inhaber | in % |
|---|---|
| Freefloat | 99,39 |
| The Vanguard Group, Inc. | 8,53 |
| Vanguard Group, Inc. (Subfiler) | 8,49 |
| T. Rowe Price Associates, Inc. (IM) | 4,77 |
| State Street Corp. | 4,23 |
| T Rowe Price Associates, Inc. (13F Subfiler) | 3,96 |
| Vanguard Total Stock Market ETF | 3,15 |
| BlackRock Fund Advisors | 2,88 |
| Vanguard 500 Index Fund | 2,64 |
| Fidelity Management & Research Co. LLC | 2,22 |
| BlackRock Institutional Trust Co. NA | 2,20 |
| Geode Capital Management LLC | 2,11 |
| Capital Research & Management Co. (World Investors) | 2,08 |
| JPMorgan Investment Management, Inc. | 1,99 |
| Invesco QQQ Trust | 1,93 |
*Die Summe der Anteile kann 100% überschreiten, da bestimmte Anteilseigner zum Freefloat dazu gerechnet wurden.
Personal
| 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Personal am Ende des Jahres | 7 326 | 8 081 | 9 793 | 12 120 | 13 676 |
| Umsatz pro Mitarbeiter in Mio. EUR | 0,61 | 0,54 | 0,58 | 0,51 | 0,52 |
Bilanz (in Mio. USD) - Aktiva
| 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Summe Umlaufvermögen | 4 663 | 6 626 | 5 845 | 6 253 | 7 888 |
| Summe Anlagevermögen | 5 071 | 4 543 | 7 710 | 6 721 | 7 636 |
| Summe Aktiva | 9 733 | 11 169 | 13 555 | 12 974 | 15 524 |
Bilanz (in Mio. USD) - Passiva
| 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Gesamtverschuldung/ -verbindlichkeiten | 76 | 80 | 87 | 94 | 90 |
| Summe Fremdkapital | 1 449 | 1 410 | 1 604 | 1 861 | 2 126 |
| Summe Eigenkapital | 8 285 | 9 759 | 11 952 | 11 113 | 13 397 |
| Summe Passiva | 9 733 | 11 169 | 13 555 | 12 974 | 15 524 |
Adresse
| 1020 Kifer Road, 94086-5304 Sunnyvale | |
| Telefon | +1 (408) 523-2100 |
| Internet | http://www.intuitive.com |
Management
|
Amal M. Johnson
Independent Director |
|
Amy L. Ladd
Independent Director |
|
Brian E. Miller
Chief Digital Officer & Executive Vice President |
|
Calvin Darling
Senior Director-Finance & Investor Relations |
|
Christopher R. Carlson
EVP-Research & Corporate Development |
|
Craig H. Barratt
Chairman |
|
Darla Hutton
VP-Asia Commercial Operations & Marketing |
|
David J. Rosa
President & Director |
|
Fredrik Widman
Principal Accounting Officer, VP & Controller |
|
Gary H. Loeb
Chief Compliance Officer & General Counsel |
|
Gary S. Guthart
Chief Executive Officer & Director |
|
Glenn Vavoso
Senior Vice President & President-Asia Pacific |
|
Henry L. Charlton
SVP, Chief Commercial & Marketing Officer |
|
Ian Purdy
Senior Vice President-Regulatory & Quality Affairs |
|
Jami K. Dover Nachtsheim
Independent Director |
|
Jamie E. Samath
Chief Financial Officer & Senior Vice President |
|
Joseph C. Beery
Independent Director |
|
Kara Andersen Reiter
Senior VP-Litigation, Privacy & Employment Law |
|
Keith R. Leonard
Independent Director |
|
Lewis Chew
Director |
|
Mark J. Rubash
Independent Director |
|
Mark P. Brosius
SVP, Chief Manufacturing & Supply Chain Officer |
|
Marshall L. Mohr
Executive Vice President-Global Business Services |
|
Monica P. Reed
Independent Director |
|
Myriam J. Curet
Chief Medical Officer & Executive Vice President |
|
Patricia L. Wadors
Chief Human Resources Officer |
|
Robert DeSantis
EVP, Chief Strategy & Corporate Operations Officer |
|
Sreelakshmi Kolli
Director |
ETF-Sparplan
Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.
